<< Back

Biography

Odysseas Kostas, M.D.

Odysseas Kostas, M.D., has served as a member of our Board of Directors since December 2017. He is a Partner and Senior Managing Director at Sarissa Capital Management LP, which he joined in 2016. Sarissa Capital focuses on improving the strategies of companies to enhance shareholder value. Prior to joining Sarissa Capital, Dr. Kostas served as a Director at Evercore ISI, covering the biotechnology and pharmaceutical industries. Prior to joining Evercore, Dr. Kostas was a Consultant and Senior Associate Analyst at Sanford C. Bernstein and Co., Inc. Previously, he practiced internal medicine as part of the Yale New Haven Health System and was engaged as a consultant to various biotechnology companies. Dr. Kostas currently serves on the board of directors of Armata Pharmaceuticals, Inc. and previously served on the board of directors of Enzon Pharmaceuticals, Inc. Dr. Kostas has a B.S. from Massachusetts Institute of Technology (MIT) and an M.D. from the University of Texas Southwestern Medical School.

    Data Provided by Refinitiv. Minimum 15 minutes delayed.

    Contact

    Toll-Free
    877-202-1097

    Innoviva Investor Relations & Media
    Sloane and Company
    212-486-9500

    For business development inquiries,
    please contact investor.relations@inva.com.